FIS 2019 speakers

Below you can find out more information about the invited speakers who will be presenting at the Federation of Infection Societies Conference 2019 (FIS 2019).

Monday 11 November

    Collaboration catalyst

  • Joanna Walker

    NHS Grampian, UK

  • Prerna Vohra

    University of Edinburgh, UK

    I earned a BSc (Hons) in Microbiology and Biochemistry from St. Xavier's College, Mumbai, in 2005. I then undertook a MSc by Research in Life Sciences in 2006 and a PhD in Medical Microbiology in 2012, both from the University of Edinburgh, and conducted fundamental research on Clostridium difficile to identify differences between five ribotypes with varied virulence in humans. During my postdoctoral research in Edinburgh, I used synthetic biology approaches in Bacteroides fragilis to develop novel oral vaccines against diarrhoeal diseases. I continued to conduct vaccine-related research at the London School of Hygiene and Tropical Medicine, where I also studied N-linked glycosylation in Actinobacillus pleuropneumoniae. I currently research host-pathogen interactions of Salmonella enterica and Campylobacter jejuni in farmed animals. I have developed and used high-throughput sequencing approaches to study virulence in vivo and am developing alternative vaccination strategies to reduce the burden of pathogens in food and improve food safety.

  • James Price

    Imperial College Healthcare NHS Trust, UK

    Dr James Price graduated in Medicine from St. George’s Hospital Medical School, London, in 2005. He undertook an Academic Foundation Programme in Infection where he begun his research in healthcare-associated infection. Following this James was awarded a Walport NIHR Academic Clinical Fellowship during which he completed his PhD focusing on whole-genome sequencing to inform nosocomial S. aureus infection. In 2014 James was appointed as a NIHR Clinical Lecturer where he continued to develop his research in prevention of healthcare-associated infection and antimicrobial resistance. His publications have received over 700 citations and he has won the prestigious Barnett Christie Prize Lecture, the Royal College of Pathologists Research Medal in Microbiology and the ESCMID Young Investigators award. He is a fellow of the Royal College of Pathologists and Trustee of the Healthcare Infection Society. He currently works at Imperial College Healthcare NHS Trust as a Consultant in Infection Prevention and Control.

  • Andrew Edwards

    Imperial College London, UK

    I am a senior lecturer in the MRC Centre for Molecular Bacteriology and Infection and my research focuses on the mode of action of antibiotics, mechanisms of resistance and the development of novel therapeutics. My group works with clinicians, chemists and engineers to design new ways of using existing antibiotics better, as well as designing small molecule inhibitors of new bacterial targets.

    I began my academic career with a PhD at the University of Bristol, followed by post-doctoral positions at the University of Minnesota, Novartis Vaccines, and the University of Bath. I’m a member of the Prokaryotic Division of the Microbiology Society and am currently co-organising the Antimicrobial Resistance and Mechanisms conference run by the British Society for Antimicrobial Chemotherapy. I’m also a member of the MRC CMBI’s training and development committee, which seeks to promote the career development of both post-graduate and post-doctoral researchers.

Tuesday 12 November

    Antimicrobial prophylaxis the impact of resistance

  • Noha El Sakka

    NHS Grampian, Aberdeen Royal Infirmary, UK

    Dr Noha El Sakka MBChB, MD, PhD, FRCPath Consultant and Service Clinical Director Medical Microbiology and Virology - NHS Grampian MBChB from Alexandria Faculty of Medicine (Egypt, 1991). Obtained PhD in molecular pathology from the University of Aberdeen in 2005, and an MD in Clinical Pathology from Alexandria Faculty of Medicine in 2006. Following 2 years of post-doctoral research follow post at the University of Aberdeen, I joined the Medical Microbiology training in Scotland (Edinburgh and Aberdeen). Obtained the FRCPath in 2013 and appointed as a Consultant of Medical Microbiology in NHS Grampian in 2015, where I am currently the Service Clinical Director. Senior Clinical lecturer in Medical Microbiology (honorary) Deputy Director of the Centre of Bacteria for Health and Disease (University of Aberdeen) Member of the Medical Microbiology Specialist advisory committee - RCPath Member of the Scottish Regional Council - RCPath Specialist Advisor to the CMO - Scotland.

  • Simon Warren

    Royal Free London NHS Foundation Trust, London, UK

  • Arthur McPhee

  • Stewardship and diabetic foot infection: “the right antibiotic, at the right dose at the right time” – and the right surgery

  • Simon Platt

    Gold Coast University Hospital, Gold Coast, Australia

    Dr Simon Platt is an orthopaedic surgeon who subspecialises in foot and ankle surgery. He practises at the Gold Coast University Hospital, previously working in the UK. He has practice and research interests in complex deformity, diabetes, neuropathy, infection, central mediation of pain, understanding of risk and the influence of non-mechanical factors on outcome following orthopaedic surgery. He currently leads a number of studies investigating surgical outcomes and the interaction between pain and foot disease. He has practised as a specialist since December 2005, qualifying in medicine in 1993. Simon Platt presents work both nationally and internationally; with over 100 abstracts accepted for presentation. He is widely published in his field. He is regularly invited as a speaker and key opinion leader particularly in the field of the diabetic foot. He is a Senior Lecturer at Griffith University and an Honorary Adjunct Associate Professor at Bond University.

  • Upendram Srinivas-Shankar

    Wirral University Teaching Hospital, UK

    Dr Srinivas-Shankar, MD, FRCP, PhD, FHEA, is a consultant endocrinologist at Wirral University Teaching Hospital, UK. He has been managing patients with diabetes foot disease for 15 years with special interest in medical management of osteomyelitis, foot infections in hemodialysis and peripheral arterial disease. He has one of the largest series of patients with diabetes foot infection managed with outpatient parenteral antibiotics. Working with a multidisciplinary team he has managed to reduce the incidence of major amputations in 2 counties in UK. His interests include medical education and works closely with the University of Liverpool. He has presented his clinical work at national and international conferences and published over 70 abstracts, papers and text books chapters, including a chapter in the Oxford text book of Medicine. He enjoys going to the gym & watching flash mobs on YouTube!

  • Mathew Diggle

    University of Alberta, Edmonton, Canada

    A proud father of three wonderful children and married to an equally wonderful and patient wife. Of other importance and significance, I’m also a Clinical Microbiologist at Alberta Public Laboratories based in Edmonton, Alberta. I originally trained in Glasgow and London, and worked in Nottingham. Over the past several decades I have worked within Clinical Microbiology and infectious diseases at various senior and leadership positions and hold honorary posts at world leading Universities, supporting a range of research (both clinical and non-clinical) and currently sit on the International Working Group for Diabetic Foot Infection (IWGDF). I’ve also supported the National Institute for Health Research UK (NIHR) within Infection and was the national lead for diagnostics. I have also been a board member of the National Pathology Board UK (NHSi) Executive.

  • Gillian Jackson

    Wirral University Teaching Hospital NHS Trust, UK

    Gillian Jackson is a Consultant Orthopaedic and Trauma Surgeon. She works at Wirral University Teaching Hospitals in Merseyside. She has a specialist Foot and Ankle trauma and elective practice including the management of neuropathic foot conditions and the associated infective complications. She manages a range of musculoskeletal infections including bone, joint and soft tissue in her general orthopaedic practise. Ms Jackson has published and presented on a number of MSK infection topics including the use of local delivery antibiotics, bone biopsy techniques in the foot and ankle and the orthopaedic manifestation and outcomes of methicillin-sensitive Staphylococcus aureus septicaemia. She was one of the founding members of the Wirral Infected Foot MDT.

  • Things that go bump in the night - dealing with the out of hours paediatric call!

  • Elisabeth Whitaker

    Paediatric Infectious Diseases Consultant, Imperial College London, UK

  • Marieke Emonts

    Paediatric Infectious Diseases consultant, Great North Children’s Hospital, Newcastle, UK

  • James Hatcher

    Microbiology Consultant, Great Ormond Street Children’s Hospital, UK

    Dr James Hatcher is a Consultant Microbiologist at Great Ormond Street Hospital for Children and honorary Consultant at the Hospital for Tropical Diseases. His specialist interests include multi-drug resistant Gram negative infections, OPAT and antimicrobial stewardship. He is joint lead for antimicrobial stewardship and has recently helped set up the UK Paediatric AMS network.

  • Challenging biofilm infection diagnosis

  • Bridget Atkins

    Oxford University Hospitals NHS Foundation Trust, UK

    Dr Bridget Atkins is a full time clinical microbiologist and infectious diseases physician in Oxford University Hospitals NHS Foundation trust. She is one of the Oxford Bone Infection Unit (BIU) physicians (clinical lead 2013-2018) with responsibility for triaging referrals, direct in-patient care on the 24 bed ward and for multidisciplinary clinics with orthopaedic and plastic surgeons. The unit is a tertiary referral centre for complex infections in orthopaedic patients from across the UK. She has published studies on laboratory diagnostics including a seminal paper on multiple intra-operative sampling (J.Clin Microbiol 1998).  She is involved in research, publications and guidelines relating to management of bone and joint infections. She is a regular invited speaker at national and international meetings. She is also Microbiology & Infectious Diseases Training Programme Director, HE Thames Valley and Chair of the RCPath Medical Microbiology training committee.

  • Gordon Ramage

    University of Glasgow, UK

    Prof Gordon Ramage works at the University of Glasgow School of Medicine, Dentistry and Nursing. He is the Treasurer for the European Society for Clinical Microbiology & Infectious Disease (ESCMID) Study Group for Biofilms (ESGB) and recently organised the successful Eurobiofilms 2019 in Glasgow. He is also a consortium member of the BBSRC’s National Biofilm Innovation Centre (NBIC), and plays a key opinion leader role for GlaxoSmithKline, Gilead Sciences and BluTest Laboratories. Prof Ramage has over 20 years of experience working in the field of clinically important biofilms. He specialises in developing pre-clinical biofilm models to explore new antimicrobial treatments for human health. Working closely with GSK and other industry partners he has pioneered the development of complex biofilm models that have been conceived from clinical microbiome analyses. These robust models serve as platforms for testing anti-biofilm technologies, including killing, inhibition and dispersal.

  • Congenital infection young people in adult services

  • Elizabeth Hamlyn

    Elizabeth Hamlyn is a consultant physician and Clinical Lead for HIV services at Kings College Hospital, London, providing inpatient and outpatient HIV care to a diverse population, including a large adolescent HIV transition and young person’s service.  She is safeguarding lead for sexual health and HIV, and sits on the British Association for Sexual Health and HIV (BASHH) Adolescent Special Interest committee.  She is also a physician for the Kings Adolescent Outreach service, which provides holistic support to 15-19 year old inpatients admitted under any specialty to adults wards.  She is an investigator on several clinical trials involving adolescents living with HIV. Her doctoral thesis examined the role of immune activation and inflammation in HIV infection. She graduated from University of Bristol, UK, and completed postgraduate training in HIV and Sexual Health Medicine in London and Australia. 

  • Use of antimicrobials at the end of life

  • Jack Fairweather

    Royal College of Physicians and Surgeons of Glasgow (RCPS), UK

    Jack is a renal and general internal medicine trainee in the West of Scotland. He was a Scottish Clinical Leadership Fellow, based with the Royal College of Physicians and Surgeons of Glasgow for 2018-19. He worked closely with the Scottish Antimicrobial Prescribing Group at Healthcare Improvement Scotland and has been involved in the establishment of a national working group examining the use of antibiotics towards the end of life.

    Jack studied at the University of Glasgow, graduating in medicine in 2009. He has worked in training rotations around the West of Scotland as well Melbourne, Australia.

  • Achyut Guleri

    Blackpool Teaching Hospitals NHS Foundation Trust, UK

    Dr Guleri is a Consultant Infection (Clinical Microbiology) at Blackpool Teaching Hospitals NHS Foundation Trust since 2006, and Honorary Senior Clinical Lecturer at the University of Central Lancashire.

    He is Lead Consultant Infection for Lancashire Cardiac Centre, and has special interest in clinical mycology, ICED infections/Endocarditis, OPAT, Bone & Joint Infections. He is actively involved in clinical research as chief investigator and/or principal investigator for several infectious diseases trials and has active research links with Lancaster University and University of Central Lancashire.

  • Susan Galbraith

    East Renfrewshire Health and Social Care Partnership, UK

    Susan Galbraith is currently the Lead for Prescribing and Clinical Pharmacy in East Renfrewshire Health and Social Care Partnership which is part of NHS Greater Glasgow and Clyde. Following her training in Glasgow Royal Infirmary and a few years in Community Pharmacy, Susan moved to a Medicines Management role in primary care in 2005. It was during this time Susan became interested in the variation in prescribing of antibiotics and was the primary care Pharmacy lead for the introduction of infection management guidelines in primary care in NHSGGC in 2009. Susan project managed this study, funded by the Scottish Infection Research Network focussing on the appropriateness of antibiotic prescribing in Palliative Care both within adult hospices and within GP practices.

  • Neglected tropical diseases

  • David Mabey

    London School of Hygiene and Tropical Medicine (LSHTM), UK

    David Mabey is a physician specialising in Infectious and Tropical Diseases. After training in the UK, he went to work at the Medical Research Council unit in The Gambia, West Africa in 1978, and was in charge of clinical services there from 1982-86. He joined the School as a Senior Lecturer in the Department of Clinical Sciences in 1986, and was made Professor of Communicable Diseases in 1994. He is an Honorary Consultant Physician at the Hospital for Tropical Diseases in London. He was head of the Clinical Research Unit in the School from 1995-2002, and has been Director of the Wellcome Trust Bloomsbury Centre for Clinical Tropical Medicine/Global Health Research since 1995. He has been a member of the Scientific and Technical Advisory Group of the WHO Department of Reproductive Healh and Research, and is Director of the WHO Collaborating centre for the Prevention and Control of Sexually Transmitted Infections at the School.  He is currently a member of the Scientific and Technical Advisory Group of the WHO Department of Neglected Tropical Diseases. He is a member of the WHO Global Alliance for the elimination of trachoma, and has sat on the Trachoma Expert Committee of the International Trachoma Initiative. He was awarded the CBE in 2014 for services to health development in Africa and Asia.

  • David Molyneux

    Liverpool School of Tropical Medicine, UK

    Professor David Molyneux is an Honorary Professor in The Liverpool School of Tropical Medicine. His research interests have been on tropical parasites and vectors and their control advising WHO on trypanosomiasis, onchocerciasis, lymphatic filariasis, guinea worm and malaria control. He has published extensively and acted as a consultant to many organisations. He has received several awards for his work from universities and learned societies. He has been one of the major advocates for increased resources for neglected tropical diseases.

  • Steve Walker

    University College London Hospital NHS Foundation Trust, UK

  • Zoonoses: so many ways to become infected

  • Roger Evans

    Dr Roger Evans is a Consultant Clinical Scientist at the Microbiology Department, Raigmore Hospital, Inverness. He is the Director of the Scottish Microbiology Reference Laboratories situated in the hospital which includes Lyme Disease and other Tick-borne Infections. The reference laboratory provides a diagnostic service as well as epidemiological data for Scotland. Current research interests are identifying markers of active Borrelia infection, analysis of different diagnostic methodologies and providing more accurate data for Lyme disease in Scotland. 

  • Joanna Lawes

    Animal and Plant Health Agency, UK

  • Geoffrey Foster

    SRUC Veterinary Services, UK

    Geoff Foster is a microbiologist with Scotland’s Rural College in Inverness. Currently he manages SRUC’s Zoonoses and Antimicrobial Resistance activities funded under the Scottish Government’s Veterinary Advisory Service. He has a broad background in the microbiology of companion, farm and wildlife animal species, inhabiting land, sea and air as well as the transfer of organisms to and from humans. His PhD thesis was entitled ‘Gram-negative bacteria infecting marine mammals’ and he has over 130 peer-reviewed publications.

Wednesday 13 November

    The role of informatics and big data in improving surveillance to address AMR and IPC - a national and global perspective

  • Eleri Davies

    Public Health Wales, UK

  • Susan Hopkins

    Public Health England, UK

    Susan Hopkins was appointed in April 2018 as the Deputy Director, National Infection Service of Public Health England leading on healthcare-associated infections and antimicrobial resistance.  She is also the Clinical Director of Infection Services at the Royal Free London NHS Foundation Trust. She trained in infectious diseases, microbiology and epidemiology in Ireland, US, France and the UK. She was appointed in 2006 as a consultant in infectious diseases and microbiology, leading the hospital epidemiology programme at the Royal Free. She holds honorary academic appointments at UCL and Imperial. She works with both the Imperial and Oxford NIHR Health Protection Research Units on HCAI & AMR.

  • Herman Goosens

    University of Antwerp, Belgium

  • Cristina Soguero-Ruiz

    Rey Juan Carlos University, Spain

    Cristina Soguero-Ruiz received the Telecommunication Engineering degree, the B.Sc. in Business Administration and Management, and the M.Sc. in Biomedical Engineering from the University Rey Juan Carlos, Madrid, Spain. She got the Ph.D. degree in Machine Learning with Applications in Healthcare in 2015 in the Doctoral Program in Multimedia and Communications in conjunction with University Rey Juan Carlos and University Carlos III. She was supported by FPU Spanish Research and Teaching Fellowship. She won the Orange Foundation Best PhD Thesis Award by the Spanish Official College of Telecommunication Engineering. She has published more than 30 papers in JCR journals and international conference communications. She has participated in several research projects (with public and private fundings) related to healthcare data-driven machine learning systems. She coordinates a pioneer Degree Program on Biomedical Engineering, involving Hospitals and Companies in the eHealth field. Her main research interests include machine learning with applications to healthcare domain.

  • Lynsey Patterson

    (Public Health Agency, Northern Ireland)

    Dr Lynsey Patterson is the Head of Health Protection Surveillance at the Public Health Agency. She holds an MSc Epidemiology from the London School of Hygiene and Tropical Medicine and she has completed the UK Field Epidemiology Training Programme. Prior to her current role, Lynsey was the surveillance lead for healthcare-associated infections and antimicrobial resistance and was responsible, most recently, for establishing enhanced surveillance for Gram-negative bacteraemias as well as dashboards for monitoring antimicrobial consumption in secondary care. The success of this development was recognized at the 2019 Antibiotic Guardian Awards where the team picked up a highly commended award in the Technology and Innovation category. Lynsey also holds an honorary research fellow position at the Centre for Public Health, Queen’s University Belfast where her interests include infectious diseases and pharmaco-epidemiology.

  • The human microbiota in health and disease

  • Alan Walker

    University of Aberdeen, UK

    I am a microbiologist by training with specific interests in the bacteria that inhabit the gastrointestinal tracts of mammalian hosts. After receiving a BSc (Hons) in Microbiology from the University of Aberdeen I studied for my PhD at the Rowett Institute and at the University of Dundee, specialising in gut microbiology and the role that intestinal anaerobic bacteria play in the breakdown of dietary fibre. Following my PhD I spent eight years at the Wellcome Sanger Institute before moving to my current post as a Senior Lecturer at the University of Aberdeen. My lab’s current research uses a combination of anaerobic culturing and DNA sequencing techniques to better characterise gut microbial communities. Our main areas of interest are investigating links between host diet, the gut microbiota and health, and the ways in which the intestinal microbiota protects the host from invading pathogenic microbes.

  • Garry Blakely

    University of Edinburgh, UK

    After gaining a PhD from the Queen’s University of Belfast I undertook postdoctoral work at the Universities of Glasgow and Oxford studying the mechanisms of site-specific recombination and chromosome segregation in bacteria. Following the award of a Wellcome trust CDR Fellowship in 1998, I moved to the University of Edinburgh. My current work uses genomics, genetics and biochemistry to understand the interactions between the microbiota and the mammalian host. My lab is also interested in the mechanisms of bacterial polysaccharide biosynthesis and their exploitation for medical and biotechnological purposes.

  • Lesley Hoyles

    Nottingham Trent University, UK

  • Vaios Svolos

    University of Glasgow, UK

    Dr Vaios Svolos is a Post-Doctoral Research Associate at the University of Glasgow. His research is focusing on the dietary manipulation of the gut microbiome and the development of a novel, solid food-based, dietary treatment for Crohn's disease; the CD-TREAT diet. He has graduated a Bsc in Dietetics and Human Nutrition from Harokopio University of Athens and completed his postgraduate studies with an Msc in Clinical Nutrition and a PhD in the dietary therapy of Crohn's disease from University of Glasgow. He is a registered dietitian in Greece.

  • Use of aminoglycosides – benefits and adverse effects

  • Robin Howe

    University Hospital of Wales, Cardiff

  • Alasdair MacGowan

    Southmead Hospital Bristol, UK

  • Yvonne Semple

    Golden Jubilee National Hospital, UK

  • Travel medicine: biting back: status and prevention of a trio of travel related infections

  • Emma Aarons

  • Katherine Russell

  • Patricia Schlagenhauf

    Patricia Schlagenhauf is a Professor and Senior Scientist at the University of Zürich, WHO Collaborating Centre for Travellers’ Health, Epidemiology, Biostatistics and Prevention Institute. She is Co-Director of the Zurich WHO Collaborating Centre for Travellers’ Health. Her main research areas are travellers’ malaria, epidemiology and prevention of travel-associated illness and gender issues in travel medicine. She is GeoSentinel Site Director and Editor-in-Chief of the Journal of Travel Medicine and Infectious Disease. She has authored more than 140 travel medicine papers and 4 books.

  • Symposium on NICE antimicrobial prescribing guidelines on pneumonia (CAP and HAP), cellulitis and diabetic foot infection

  • Tessa Lewis

  • Susan Hopkins

    Public Health England, UK

    Susan Hopkins was appointed in April 2018 as the Deputy Director, National Infection Service of Public Health England leading on healthcare-associated infections and antimicrobial resistance.  She is also the Clinical Director of Infection Services at the Royal Free London NHS Foundation Trust. She trained in infectious diseases, microbiology and epidemiology in Ireland, US, France and the UK. She was appointed in 2006 as a consultant in infectious diseases and microbiology, leading the hospital epidemiology programme at the Royal Free. She holds honorary academic appointments at UCL and Imperial. She works with both the Imperial and Oxford NIHR Health Protection Research Units on HCAI & AMR.

  • Paddy McMaster

  • Vaccine preventable disease

  • James Lopez Bernal

  • Pauline Paterson

    London School of Hygiene & Tropical Medicine, UK

    Dr Pauline Paterson is an Assistant Professor in the Department of Infectious Disease Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), UK and is Co-Director of The Vaccine Confidence Project. Dr Paterson has been researching issues of public confidence in immunisations since 2010.

  • Zahin Amin-Chowdhury

    Pubic Health England, UK

    Zahin Amin-Chowdhury is an epidemiological scientist at Public Health England within the Immunisation and Countermeasures Division, where she has been working for the last four years. Currently, she is involved in maintaining the surveillance of and undertaking research on invasive pneumococcal disease in England. Prior to working at Public Health England, she completed a degree in Biomedical Science. Zahin is also undertaking an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine in her spare time. Some of her main interests include vaccine-preventable diseases and getting involved in public health outreach.

  • Anaerobe update

  • Jane Freeman

  • John Hood

    Glasgow Royal Infirmary, UK

  • Michael Perry

    Public Health Wales, UK

Thursday 14 November

    NITCAR@FIS

  • Jordan Skitrall

  • Susanne Hodgson

    University of Oxford, UK

    Susanne Hodgson is an NIHR Academic Clinical Lecturer in Infection at the University of Oxford. She is co-founder of the UK Necrotising Otitis Externa (NOE) collaborative and lead for NITCAR's Prospective Study of NOE in the UK.

  • Demystifying RCPATH exams

  • Malur Sudhanva

    King's College Hospital NHS Foundation Trust, UK

    Dr Sudhanva has been the Chair of Panel of Examiners for Virology at Royal College of Pathologists since 2018, primarily running the part 2 exams. Prior to this, he was the virology lead for the old FRCPath part 1 examination since 2013. He was right at the preparation stage and inception of the new FRCPath part 1 / CICE examination since 2013. He is still involved current FRCPath part 1 / CICE examinations as Standard Setter. He has established the Virology “Style” and has helped establishing the Microbiology Style. He is a consultant medical virologist at King’s College Hospital NHS Foundation Trust in London since 2004. He is also the Clinical Director of Viapath’s Pathology Laboratories at King’s College Hospital since 2017. Between 2010 and 2016, he worked at Rare and Imported Pathogens Laboratory (RIPL), PHE Porton Down as Honorary Consultant Virologist and on-call for UK Imported Fever Service.

  • Ronan McMullan

    Belfast Trust and Reader at Queen’s University Belfast, UK

    Ronan McMullan is a consultant microbiologist at Belfast Trust and Reader at Queen’s University Belfast. He undertakes clinical research on diagnostic tests for infection in the critical care setting and his main focus is on diagnostic accuracy studies. He is a member of the NIHR HTA programme’s prioritisation committee for hospital-based research. Ronan has been Chair of the Medical Microbiology Examiners’ panel at the Royal College of Pathologists since 2017, having served as an examiner for both FRCPath part 1 and 2 examinations since 2009. He also works as an education associate with the General Medical Council, contributing to the review of postgraduate curricula and assessment systems.

  • Alice Wort

    Newcastle upon Tyne Hospitals NHS Foundation Trust, UK

  • Robert Shorten

Plenary Lectures

    Healthcare Infection Society Lowbury Lecture

  • Petra Gastmeier

    Institute of Hygiene and Environmental Medicine, Germany

    After specialization in hygiene and environmental medicine, Petra Gastmeier worked from 1991 to 2000 as a hospital epidemiologist in Potsdam and the university hospital of the Free University Berlin. During this time, she created the German national surveillance system for healthcare associated infections (KISS) with meanwhile more than 1300 participating hospitals. From 2001 to 2007, she was Associated Professor of Hospital Epidemiology at Hanover Medical University. Since 2008, she is Full Professor for Hygiene and Environmental Medicine at Charité –University Medicine in Berlin.

    Her research focuses on the investigation of the epidemiology of healthcare associated infections, multiresistant organisms and antibiotic usage in hospitals. She is and has been PI or Co-PI of several large epidemiological studies investigating the effect of various interventions on the occurrence of healthcare associated infections. She also established the German national hand hygiene campaign, which is meanwhile running for more than 10 years.  

  • Microbiology Society Plenary Lecture

  • Robin Patel

    Mayo Clinic, USA

    Dr Robin Patel graduated from Princeton University with a BA in Chemistry and from McGill University in Montreal, Canada with an MD. She then moved to Rochester, Minnesota, where she completed a residency in Internal Medicine and fellowships in Infectious Diseases and Clinical Microbiology at the Mayo Clinic. Upon completion of post-graduate training, she joined the staff of the Mayo Clinic. She is currently Professor of Medicine and Professor of Microbiology, the Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, Co-Director of the Clinical Bacteriology Laboratory, Director of the Infectious Diseases Research Laboratory, and Chair of the Division of Clinical Microbiology, at Mayo Clinic. Dr Patel is board certified in Infectious Diseases (American Board of Internal Medicine), Medical Microbiology/Public Health Microbiology (American Board of Medical Microbiology), Clinical Pathology/Medical Microbiology (American Board of Pathology), and Internal Medicine, Medical Microbiology and Infectious Diseases (Collège des Médecins du Québec and Royal College of Physicians and Surgeons of Canada). Dr Patel’s research focuses on clinical bacteriology diagnostic testing, antimicrobial resistance, and microbial biofilms. She has published over 400 peer reviewed manuscripts and has delivered numerous national and international presentations. She is a Fellow of American Academy of Microbiology, past chair of the United States Medical Licensing Examination Microbiology and Immunology Test Material Development Committee, past co-chair of the ASM Microbe 2016–2018 Program Planning Committee, member of NIAID Council, advisor for the CLSI Subcommittee on Antimicrobial Susceptibility Testing, member of the American Board of Pathology Medical Microbiology and Clinical Pathology for ABPath CertLinkTM Test Development and Advisory Committees, and ASM President. She is an associate editor for Clinical Infectious Diseases and course director for the Mayo Medical School Microbiology course.

  • BIA Plenary Lectures

  • Paul Griffiths

    University College London, UK

    Paul Griffiths is Professor of Virology at University College, London. He is Editor-In-Chief of Reviews in Medical Virology. His research concerns cytomegalovirus infection, where he has helped to define the natural history and pathogenesis of this infection and used this information to design randomised controlled trials of antiviral drugs and prototype vaccines. Selected relevant peer-reviewed publications are listed below:

    Atabani SF et al. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by pre-emptive therapy. American Journal of Transplantation (2012) 12: 2457-64.

    Baraniak I et al. Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine with MF59: Anti-AD2 Levels Correlate with Protection from Viremia. J Infect Dis. (2018) 217: 1907-1917.

    Baraniak I et al. Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies. Proc Natl Acad Sci U S A. (2018) 115: 6273-6278.

  • Tom Parks

    Tom is a postdoctoral clinician scientist training in infectious diseases and general internal medicine. He is currently a specialist registrar at the Hospital for Tropical Diseases in London but also holds visiting academic positions at the London School of Hygiene & Tropical Medicine and the University of Oxford. His research investigates host genetic susceptibility to group A streptococcal disease with particular focus on rheumatic heart disease and invasive infection. Prior to arriving in London, he was based at the Wellcome Trust Centre for Human Genetics, Oxford, where, through a Medical Research Council Clinical Research Training Fellowship, he undertook his doctoral studies under the supervision of Professor Adrian Hill, University of Oxford, and Professor Andrew Steer, University of Melbourne. To date he has been awarded research grants from the British Heart Foundation, British Medical Association, European Society of Clinical Microbiology and Infectious Diseases as well as the Sir Halley Stewart Trust.